Jagsonpal Pharmaceuticals Buyback 2026 vs Matrimony Buyback 2026 Details

Comparison between Jagsonpal Pharmaceuticals Buyback 2026 and Matrimony Buyback 2026 Details.

Buyback Details

Jagsonpal Pharmaceuticals Buyback 2026 is a Tender Offer buyback proposed to list at NSE, BSE while Matrimony Buyback 2026 Details is a Tender Offer proposed to list at BSE, NSE.

 Jagsonpal Pharmaceuticals Ltd.Matrimony.com Ltd.
LogoJagsonpal Pharmaceuticals Buyback 2026 LogoMatrimony Buyback 2026 Details Logo
Type of BuybackTender OfferTender Offer
Listing AtNSE, BSEBSE, NSE
Face Value₹10 per share₹5 per share
Buyback Price₹250 per share₹655 per share
Issue Size16,00,000 shares8,93,129 shares
Issue Size (Amount)₹40.00 Crores₹58.50 Crores
Buyback Ratio
CategoryEntitlement RatioShares Offered
Small Shareholders47 : 6372,40,975
General Category47 : 63713,59,025

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

CategoryEntitlement RatioShares Offered
Small Shareholders8 : 751,33,970
General Category4 : 457,59,159

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

RegistrarMCS Share Transfer Agent Ltd.Kfin Technologies Ltd.
Lead ManagersCentrum Capital Ltd.Saffron Capital Advisors Pvt.Ltd.
Necessity of the buyback

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Improve financial ratios such as earnings per share and return on equity.

The Buyback is undertaken for the following reasons:

  1. The Buyback will help the Company to distribute surplus cash to its shareholders holding Equity Shares thereby enhancing the overall return for them.
  2. The Buyback, which is being implemented through the tender offer route as prescribed under the SEBI Buyback Regulations, would involve a reservation of up to 15% of the Equity Shares, which the Company proposes to buyback, for small shareholders or the actual number of Equity Shares entitled as per the shareholding of small shareholders on the Record Date, whichever is higher. The Company believes that this reservation for small shareholders would benefit a significant number of the Company’s public shareholders, who would be classified as “Small Shareholders”.
  3. The Buyback is generally expected to improve return on equity through distribution of cash and improve earnings per share by reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders’ value; and
  4. The Buyback gives an option to the Eligible Shareholders to either (A) participate in the Buyback and receive cash in lieu of their Equity Shares which are accepted under the Buyback, or (B) not to participate in the Buyback and get a resultant increase in their percentage shareholding in the Company post the Buyback, without additional investment.

Buyback Timetable

Jagsonpal Pharmaceuticals Buyback 2026 and Matrimony Buyback 2026 Details buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Jagsonpal Pharmaceuticals Buyback 2026 Buyback record date is May 04, 2026. Matrimony Buyback 2026 Details Buyback record date is Jan 30, 2026.

 Jagsonpal Pharmaceuticals Ltd.Matrimony.com Ltd.
Record DateMay 04, 2026Jan 30, 2026
Offer Open DateMay 08, 2026Feb 05, 2026
Offer Closure DateMay 14, 2026Feb 11, 2026
Last date for receipt of tender formsMay 15, 2026Feb 12, 2026
Finalisation of buybackMay 20, 2026Feb 17, 2026
Last Date for settlment of bidsMay 21, 2026Feb 18, 2026
Last Date for extinguishment of sharesJun 02, 2026Feb 27, 2026

Financial Details and Other Relevent Information

Comparison of Jagsonpal Pharmaceuticals Buyback 2026 and Matrimony Buyback 2026 Details financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Jagsonpal Pharmaceuticals Ltd.Matrimony.com Ltd.
Financial

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets278.26217.08194.95
Total Income276.91217.98242.45
Profit After Tax55.3622.4626.72
Reserves and Surplus226.67174.18145.79
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202531 Mar 202531 Mar 2024
Total Income112.41447.00472.79
Profit After Tax7.5544.9348.45
NET Worth247.09241.91292.08
Reserves and Surplus236.31231.13280.95
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 513.90 270.05 377.81
Jan-2025 283.55 196.50 225.44
Jan-2026 301.80 154.90 215.07

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Dec-2025 561.10 475.55 517.55
Nov-2025 535.00 456.75 504.16
Oct-2025 544.85 502.45 512.20
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 514.85 273.60 377.59
Jan-2025 284.36 196.35 225.37
Jan-2026 301.65 155.00 214.95

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Dec-2025 560.50 475.00 517.57
Nov-2025 545.00 475.25 504.22
Oct-2025 546.60 500.15 511.70

Compare with others

Compare:

Jagsonpal Pharmaceuticals Buyback 2026 and Matrimony Buyback 2026 Details